TEVA fund manager activity
Teva Pharmaceutical Industries Limited · NYSE. Reported by 18 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.
Q2 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | New | 100,000 | $1,676,000 | 0.00% | Aug 14, 2025 |
| Stanley Druckenmiller - Duquesne Family Office | Added | 15,968,935 | $267,639,000 | 6.84% | Aug 15, 2025 |
| Jeremy Grantham - GMO | New | 15,337 | $257,048 | 0.00% | Aug 13, 2025 |
| David Einhorn - Greenlight Capital | Added | 3,778,777 | $63,332,302 | 2.72% | Aug 14, 2025 |
| Lee Ainslie - Maverick Capital | Added | 4,377,690 | $73,370,084 | 1.13% | Aug 14, 2025 |
| Harry Burn - Sound Shore | Added | 5,846,512 | $97,987,541 | 3.34% | Aug 6, 2025 |
| Viking Global Investors | Added | 11,681,333 | $195,779,141 | 0.57% | Aug 14, 2025 |
Q1 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Stanley Druckenmiller - Duquesne Family Office | Added | 14,879,750 | $228,702,000 | 7.67% | May 15, 2025 |
| David Einhorn - Greenlight Capital | Added | 568,200 | $8,733,234 | 0.44% | May 15, 2025 |
| Lee Ainslie - Maverick Capital | Added | 30,292 | $465,588 | 0.01% | May 15, 2025 |
| Bill Miller - Miller Value Partners | Sold out | — | — | 0.00% | May 15, 2025 |
| Samantha McLemore - Patient Capital Management | Sold out | — | — | 0.00% | May 14, 2025 |
| Harry Burn - Sound Shore | Added | 5,452,089 | $83,798,608 | 2.94% | May 6, 2025 |
| Viking Global Investors | Added | 10,125,478 | $155,628,597 | 0.49% | May 15, 2025 |
Newer quarters · Older quarters